Grant

Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

CountryUnited States
Deadline2028-09-25 (673 days left)
Published2026-06-09
SectorsHealth & life sciences, Research & innovation
SourceGrants.gov (US)

Summary

Funding opportunity PAR-27-026. CFDA: 93.279

The buyer, the value, the full description and the link to the official notice are available with a free account.